Answers are grounded in this paper and cite their sources.
Observational analysis identifies NRF2 as a promoter of T-cell activation in acute graft-versus-host disease, suggesting new therapeutic avenues.
To the Editor: The pathophysiology of acute graft-versus-host disease (aGVHD) remains a formidable challenge in allogeneic hematopoietic stem cell transplantation.1 While extensive research has focused on T-cell activation and the complex cytokine network driving the disease, few studies have questioned whether transcription factors that traditionally regulate oxidative stress might paradoxically fuel immune dysregulation.2 In this issue of Transplantation, Chen et al3 provide compelling evidence that nuclear factor (erythroid-derived 2)-like 2 (NRF2), a molecule historically associated with cellular protection, may in fact act as a pivotal promoter of T-cell hyperactivation in aGVHD. This study raises a crucial question: could NRF2, a molecule previously viewed as anti-inflammatory, play a proinflammatory role in the context of aGVHD? NRF2 has long been considered a guardian of redox homeostasis and a protective factor against tissue injury in various inflammatory settings. However, emerging evidence suggests that its role in T-cell biology may be far more complex.4 Chen et al3 demonstrated that NRF2 expression is significantly elevated in CD4+ T cells from patients with aGVHD compared with non-aGVHD controls and that this elevation correlates with disease severity. The authors further confirmed that T-cell receptor activation upregulates NRF2 expression, and intriguingly, this upregulation in turn enhances T-cell activation in a feed-forward manner. When NRF2 was pharmacologically inhibited using ML385 (MedChemExpress, NJ), a selective NRF2 inhibitor, the expression of key T-cell activation markers, including CD40LG, CD69, and CD137, was markedly reduced. These findings suggest that NRF2 is not merely a bystander but an active amplifier of T-cell activation in the inflammatory milieu of aGVHD. To better understand the mechanistic underpinnings of NRF2's involvement, the authors performed transcriptomic profiling of CD4+ T cells following NRF2 overexpression. They identified substantial changes in gene expression, particularly within pathways related to T-cell receptor signaling, T helper 17 cells (Th17) differentiation, and the JAK1-STAT1 axis. These findings are particularly noteworthy because the JAK1-STAT1 signaling pathway is known to drive pathogenic T-cell responses and has been implicated in aGVHD progression. Chen et al3 further confirmed that NRF2 overexpression upregulates IFNGR2 (anti–IFN-γ receptor 2) and STAT1 at both the mRNA and protein levels, reinforcing the hypothesis that NRF2 exacerbates proinflammatory signaling cascades. Pharmacologic inhibition of NRF2 in aGVHD patient-derived CD4+ T cells successfully downregulated these signaling components, along with a significant reduction in Th17 cell differentiation and interleukin-2 secretion.5 A particularly valuable aspect of this study is its focus on the Th17/regulatory T cells (Treg) balance, which has emerged as a critical determinant of aGVHD severity. The authors demonstrated that NRF2 inhibition not only suppressed Th17 differentiation but also appeared to mildly favor Treg-associated gene expression, although this effect was not statistically significant. This subtle shift suggests that NRF2 may predominantly promote proinflammatory Th17 responses rather than directly inhibiting Treg differentiation. Whether NRF2's influence on the Th17/Treg axis is clinically meaningful will require further investigation, particularly in in vivo transplantation models. These findings offer a fresh perspective on the immunobiology of aGVHD and raise important translational questions. Can targeting NRF2 be developed into a feasible therapeutic strategy to mitigate T-cell hyperactivation without compromising essential protective functions? NRF2 has been widely studied for its cytoprotective effects in other organ systems, and systemic inhibition of NRF2 may inadvertently increase susceptibility to oxidative injury. However, the potential to modulate NRF2 activity selectively within T cells, or to transiently inhibit NRF2 during the critical window of T-cell activation, could present an innovative and safer approach. Chen et al3 should be commended for advancing our understanding of the nuanced role of NRF2 in T-cell biology and aGVHD pathogenesis. Their work highlights the importance of reevaluating the context-dependent roles of transcription factors traditionally regarded as protective. Rather than simply acting as an anti-inflammatory molecule, NRF2 appears to adopt a proinflammatory persona within the unique immunologic landscape of aGVHD. This dual functionality emphasizes the complexity of immune regulation and underscores the need for precision-based interventions that account for cell-type-specific effects. In conclusion, this study challenges long-standing assumptions about NRF2 and provides a foundation for future research exploring NRF2 as a potential immunomodulatory target in aGVHD. The question now is not whether NRF2 is involved in T-cell-mediated pathology, but how—and when—it can be safely manipulated to restore immune balance without compromising host defense. As we move toward more personalized approaches in transplantation, understanding the multifaceted roles of key regulatory molecules like NRF2 will be essential in shaping the next generation of therapeutic strategies. These findings also complement the recent perspectives published in Transplantation, including the evolving understanding of macrophage targeting as a strategy for personalized medicine in organ transplantation, and the parallels between chronic GVHD and solid organ transplantation pathophysiology.3,6 Together, these contributions reflect a shift toward precision-based immunomodulation across transplantation settings, underscoring the importance of considering cell-type- and context-specific effects when targeting key regulators such as NRF2.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: